Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Other2.73B42.68%
Nexplanon/Implanon NXT963M15.04%
Atozet473M7.39%
Other443M6.92%
Singulair359M5.61%
Zetia317M4.95%
Other Non-Opioid Pain, Bone and Dermatology295M4.61%
Nasonex276M4.31%
Renflexis274M4.28%
Arcoxia270M4.22%
View all
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
Europe and Canada1.76B27.53%
United States1.57B24.55%
Asia Pacific and Japan1.05B16.40%
Latin America, Middle East, Russia and Africa1.03B16.15%
China847M13.23%
Other137M2.14%
View all